力大圖書

Clinical Nuclear Cardiology, 3rd Edition - State of the Art and Future Directions
By Barry L. Zaret, MD and George A. Beller, MD
Approx. 768 pages, Approx. 550 illustrations (350 in full color),
Copyright 2005
Description
This completely revised 3rd Edition delivers up-to-date coverage of the most recent developments in technology, instrumentation, and radiopharmaceuticals—and now it’s in full color! Internationally recognized experts in the field discuss the full range of nuclear cardiology applications, helping readers gain a better perspective on the current and future use of radionuclides in imaging diagnosis of the heart.
Key Features
Features the contributions of top international experts.
Comprehensively covers radiopharmaceuticals, instrumentation, tracer kinetics, perfusion imaging, metabolic imaging, and more!
New to this Edition
Provides new discussions of disease and gender-specific issues.
Includes a new Mini Atlas of Case Presentations, with highly illustrated coverage of all modalities.
Features a new section, New Molecular Approaches, with 5 new chapters: Angiogenesis * Annexin * Vascular Imaging/Detection * Gene Product Imaging * and Imaging Inflammatory Approaches
Delivers 2 new chapters on instrumentation: Attenuation/Scatter Coorection: Physics Aspects and Dynamic Cardia SPECT.
Employs a bold new full-color format throughout.
Table of Contents
I. Radiopharmaceuticals/Tracer Kinetics
Overview of Kinetics and Modeling
Kinetics on a Cellular Level
Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
SPECT Processing, Quantification, and Display
SPECT Artifacts
Attenuation/Scatter/Resolution Correction: Physics Aspects
Attenuation/Scatter Correction: Clinical Aspects
Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
The New Generation PET/CT Scanners: Implications for Cardiac Imaging
State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III. Ventricular Function
Cardiac Performance
Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging
IV. Perfusion Imaging
Coronary Artery Disease: Exercise Stress
Coronary Artery Disease Detection: Pharmacologic Stress
Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
Myocardial Perfusion Imaging Using Non-Radionuclide Techniques
Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
Imaging in Women
Imaging for Preoperative Risk Stratification
Nuclear Imaging in Patients with a History of Coronary Revascularization
Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
Radionuclide Imaging in Heart Failure and Cardiomyopathies
Imaging in Patients Receiving Cardiotoxic Chemotherapy
Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
Imaging Patients with Chest Pain in the Emergency Department
Measuring the Efficacy of Therapy in Acute
Myocardial Infarction with Technetium-99m-SESTAMIBI Imaging
Risk Stratification After ST Elevation Acute MI
Risk Stratification in Acute Coronary Syndromes
VII. Viability
Physiologic and Metabolic Basis of Myocardial Viability Imaging
Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents
Assessment of Myocardial Viability With PET
Comparison with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
Fatty Acid Imaging
Cardiac Neurotransmitter Imaging: SPECT
Cardiac Neurotransmitter Imaging: PET
Receptor Imaging
IX. New Molecular Approaches
New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
Noninvasive Detection of Cell Death in Myocardial Disorders
Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture
Molecular Imaging of Gene Products
Imaging Myocardial Inflammation
Section X: Mini-Atlas of Case Presentations